Maximal androgen withdrawal for prostate cancer therapy: current status and future potential

被引:9
|
作者
Leewansangtong, S [1 ]
Crawford, ED [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Urol, Denver, CO 80262 USA
关键词
D O I
10.1677/erc.0.0050325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:325 / 339
页数:15
相关论文
共 50 条
  • [41] Chemoprevention of prostate cancer: Current status and future directions
    Lieberman, R
    CANCER AND METASTASIS REVIEWS, 2002, 21 (3-4) : 297 - 309
  • [42] Prostate cancer screening: current status and future perspectives
    Strope, Seth A.
    Andriole, Gerald L.
    NATURE REVIEWS UROLOGY, 2010, 7 (09) : 487 - 493
  • [43] Prostate Cancer Registries: Current Status and Future Directions
    Gandaglia, Giorgio
    Bray, Freddie
    Cooperberg, Matthew R.
    Karnes, R. Jeffrey
    Leveridge, Michael J.
    Moretti, Kim
    Murphy, Declan G.
    Penson, David F.
    Miller, David C.
    EUROPEAN UROLOGY, 2016, 69 (06) : 998 - 1012
  • [44] Maximal androgen blockade for advanced prostate cancer
    Klotz, Laurence
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (02) : 331 - 340
  • [45] The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlight
    Tunn, Ulf
    BJU INTERNATIONAL, 2007, 99 : 19 - 22
  • [46] Androgen deprivation therapy for prostate cancer - the potential of parenteral estrogen
    Ockrim, Jeremy
    Abel, Paul D.
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2009, 62 (03) : 132 - 140
  • [47] Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects
    Wong, Chris Ho-Ming
    Nicoletti, Rossella
    Mazzone, Elio
    Eapen, Renu S.
    CURRENT OPINION IN UROLOGY, 2025, 35 (01) : 46 - 52
  • [48] NEWER AGENTS FOR ANDROGEN DEPRIVATION IN PROSTATE-CANCER AND THE CURRENT STATUS OF CHEMOTHERAPY FOR PROSTATE-CANCER
    SOLOWAY, MS
    BRITISH JOURNAL OF UROLOGY, 1986, 58 (01): : 89 - 89
  • [49] Experience with Androgen Deprivation Therapy for Prostate Cancer in Japan and Future Perspectives
    Kitagawa, Yasuhide
    Ueno, Satoru
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Hinotsu, Shiro
    Akaza, Hideyuki
    Namiki, Mikio
    CURRENT CANCER DRUG TARGETS, 2015, 15 (04) : 314 - 326
  • [50] Androgen deprivation therapy in prostate cancer: new findings and questions for the future
    Sartor, Oliver
    LANCET ONCOLOGY, 2019, 20 (02): : 176 - 177